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Abstract:  
Aluminium (Al) has been investigated as a neurotoxic substance. Al ranks among the potential environmental risk factors 
for Alzheimer’s disease (AD). Epidemiological studies tested the relationship between Al in drinking water and AD, 
showing a significant correlation between elevated levels of monomeric Al in water and AD, although data to date remain 
inconclusive with respect to total Al. The aim of this study was to test whether or not Al exacerbates cellular toxicity 
mediated by the amyloid β (Aβ) peptide. We evaluated the role of Al in modulating programmed cell death (apoptosis) in 
human cell cultures. We used the osteosarcoma cell line monolayer (SaOs-2) to demonstrate that treatment of SaOs-2 
cultures with the Aβ peptide mid-fragment (25 to 35) at nano
  M, followed by co-incubation with physiological 
concentrations of aluminium chloride, which release monomeric Al in solution, led to marked expression of caspase 3, but 
not caspase 9, key markers of the apoptotic process. The same experimental conditions were shown to blunt significantly the 
proliferative response of normal human peripheral blood mononuclear cells (PBMC) to phytohemagglutinin (PHA) 
stimulation. Our observations support the hypothesis that Al significantly impairs certain cellular immune responses, and 
confirm that Al-mediated cell toxicity may play an important role in AD. 
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Background: 
The cause of Alzheimer’s disease (AD) is closely 
correlated with the aggregation of the 1 to 42 Amyloid β 
(Aβ) peptide in the neocortex. The precipitation in vitro 
and in vivo, and consequential cell toxicity of Aβ is favored 
by metal ions, such as aluminium (Al) and iron (Fe). [1] An 
extensive literature has examined the putative role of Al as 
a risk factor for AD and for other neurological pathologies, 
including Parkinson’s disease and amyotrophic lateral 
sclerosis, as well as systemic diseases, such as diabetes and 
cancer.  [2, 3] The evidence to date remains mixed, 
primarily because of a range of methodological issues. No 
data to date demonstrated that the concentration of Al in the 
brains of AD patients is significantly higher than that of 
control subjects, however, detectable levels of Al have been 
reported in senile plaques and neurofibrillary tangles of 
subjects with AD. [3] Most epidemiological studies report 
total Al (Altot) as an indicator of exposure, perhaps 
because Al can be present in solution in several forms, not 
all of which are toxic. The monomeric fraction of Al 
consists of a non-water soluble component (e.g., 
monomeric organic complexes), and a water-soluble 
component. The latter is made up of free Al
3+ ions, of 
hydroxy complexes, and of inorganic complexes, including 
salts of chlorides, fluorides, sulphates, carbonates, 
phosphates, or silicates. The water soluble form of Al is 
characteristically toxic to eukaryotic cells, particularly as 
the Al
3+ ion and its hydroxy complexes. The pH of the 
physiological, cellular and cytoplasmic environment greatly 
influences the relative concentrations of these forms of Al. 
[4] 
 
Epidemiological evidence, albeit rare, suggests a significant 
correlation between onset of AD and monomeric Al. [4, 5] 
Therefore, it may be important to estimate Al speciation in 
seeking to establish the association between Al exposure 
and AD.  Bioinformation by Biomedical Informatics Publishing Group  open access 
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The fact of being exposed to high concentrations of Al 
might accentuate certain neurological, and other diseases. 
High concentrations of serum total Al (greater than 10 mg 
per L) were noted, concomitant with high blood iron levels, 
in foundry workers who demonstrated as well more 
cognitive deficiencies, compared to control subjects. [6] 
However, oral bioavailability of Al is low (approximately 
0.3 percent), and does not reflect stomach contents and 
water hardness. [7] Al may exacerbate cellular toxicity 
associated with Ab, which is thought to contribute to the 
etiology and evolution of AD.  
 
Description: 
We tested two distinct models to characterize the 
cytochemical mechanisms of Al toxicity. We used the 
established cell line of osteoblast-like osteosarcoma, SaOs-
2 as a model system to test whether or not Al mediated 
programmed cell death (i.e., apoptosis), and to elucidate 
which apoptotic pathway might be involved.  We also used 
peripheral blood mononuclear cells (PBMC) obtained from 
normal healthy elderly and young donors to test whether or 
not Al impair the proliferative response.  
 
The subjects (n = 26) for this investigation were taken from 
our common pool of adult male and female donors (18 to 
65 years of age) from the principal socio-ethnic groups in 
the U.S. Subjects signed informed consent. Subjects were 
screened for history of infectious, neoplastic and 
autoimmune diseases prior to donation.  
 
Blood samples were processed within 12 hours of 
collection (room temperature, gentle shaking) according to 
established methods. [8, 9, 10] 
 
The established human osteosarcoma cell line, SaOs-2, was 
obtained from the American Tissue Culture Collection 
(ATCC, Rockville, MD). SaOs-2 were maintained in 
exponential growth in AIM-V medium (Gibco) 
supplemented with 10 percent fetal bovine serum (Gibco). 
Viability was verified by trypan blue exclusion at each 
passage, following trypsin-mediated detachment from the 
plastic substratum (0.2 percent trypsin in 0.9 percent NaCl, 
3 min, 37 degree C). On the day of the experiment, cultures 
were adjusted at a cell concentration of 5 million cells per 
ml in growth medium for experimental plating. 
 
Aβ peptides from American Peptide Co. (Sunnyvale, CA) 
were reconstituted and stored at -70°C were used fresh for 
each experiment.  Pilot experiments established the optimal 
conditions for test of cytotoxicity in vitro t o  b e  c o -
incubation for 24 to 48 h at 1 nano M to 0.1 nano M). The 
chloride salt of Al (AlCl3; Sigma, St. Louis, MO) was used 
in these experiments, over a range of concentrations about 
nano
 M, as indicated in individual experiments. In the in 
vitro experiments we report here, the cells were cultured 
with physiological concentrations of Aβ peptides (i.e., 1 to 
42, 1 to 28, 25 to 35, and 40 to 1 as control), and Al in the 
chloride salt form and at a concentration similar to that 
reported to resemble bioavailability of Al from drinking 
waters. [7] 
 
To assess the modulation of apoptotic cell death by Al, and 
unless otherwise indicated in the text, experiments were 
plated at million cells per ml in: 1) untreated, 2) treated 
with 0.1 micro gram per ml camptothecin (CAM; Sigma) as 
control 3) treated with 0.1 micro gram per ml CAM and 
AlCl3  (nano
  M), 4) treated with Aβ  (40 to 1) anti-sense 
control peptide and AlCl3  (nano
  M), 5) treated with the 
native Aβ (1 to 42) peptide; 6) treated with the native Aβ 
(1-42) peptide and AlCl3  (nano
  M), 7) treated  with the 
amino-terminal Aβ (1 to 28) peptide; 8) treated with the 
amino-terminal Aβ (1 to 28) peptide and AlCl3 (nano M), 
9) treated with the mid-Aβ (25 to 35) peptide, 10) treated 
with the mid-Aβ (25 to 35) peptide and AlCl3 (10
-9 M). 
 
For apoptotic cell death, we  measured the cytoplasmic 
levels of nucleosomal histone protein (Roche, Indianapolis, 
IN). We identified the apoptotic pathway by 
immunocytobiochemistry by standard protocol. [11] We 
monitored caspase 3, the terminal caspase of the apoptotic 
pathway, which activates the caspase-dependent 
endonuclease for DNA fragmentation. We also assessed 
caspase 9 to test whether or not the mitochondrion-
mediated pathway of apoptosis was involved. 
 
We assessed traversal of late G1 and G1/S transition by 
monitoring the expression of cyclin D3 and of the 
phosphorylated and unphosphorylated forms of the 
retinoblastoma protein (pRb and Rb), as described 
elsewhere (Chiappelli and Liu, 1999). Immunoreactive 
bands were detected by color development, and, when dry, 
the membranes were scanned and computer analyzed with 
the Photoshop software.   
 
To assess the modulatory effects of Aβ peptides and Al on 
T cell-specific functions, we monitored the ability of 
activated T cells to generate cytotoxic T lymphocytes 
(CTL)  [11], cell proliferation after incubation with 
phytohemagglutinin (PHA) and lipopolysaccharide (LPS). 
The generation of CTL involved a 7-day incubation of 
PBMC effectors in a mixed leukocyte reaction with 
mitomycin-C-treated (50 micro gram per ml mitomycin-C, 
37 degree C, 30 min) RAJI target cells in the presence or 
the absence of the Aβ peptides and AlCl3, according to our 
established criteria. [11] 
 
All experiments were plated at million cells per ml in 5 
conditions:  1) untreated control, 2) control treated with 0.1 
micro gram per ml CAM; 3) control treated with (40 to 1, 
antisense) peptide, 4) treated with the Aβ protein (1 to 42), 
4) treated with the Aβ peptide (1 to 28), 5) treated with the 
Aβ peptide (25 to 35).  
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PHA and LPS experiments were performed as follows: 1 in 
million cells per well in complete media were exposed to 5 
micro gram per ml of PHA (Sigma Chem. Co., St. Louis, 
MO) and incubated for 48hours. Thereafter, 0.1 mL of 
medium containing LPS (100 g per mL) (E. coli; Difco, 
Detroit, MI, USA) was added to each well. The plate was 
then incubated for 48 hours in a humidified incubator at 37 
degree C in 5 percent CO2, and induction was arrested on 
ice.  
 
Data, shown as raw data or percentage of control, or 
transformed as indicated in the text, were analyzed at α = 
0.05 (Stata5, Stata Corporation, College Station, TX) by 
ANOVA when the assumptions for parametric statistics 
(normality, independence and homogeneity of variance) 
were satisfied, followed by Dunnet post-hoc comparisons 
to compare the experimental conditions to the control 
group.  If the assumptions for parametric statistics were 
violated, then the non-parametric Kruskall-Wallis, 
Friedman and Wilcoxon tests were used. The level of 
significance was set at 0.05, and corrected by Bonferroni as 
required. Optima were analyzed as described in 
Berenbaum. [12] 
 
Treatment of SaOs-2 cultures with the Aβ peptide (25 to 
35) followed by AlCl3 leads to marked expression of 
caspase 3, but not caspase 9. These observations suggest 
that the apoptotic pathway induced by this treatment does 
not involve the mitochondrial pathway. Those results were 
confirmed by Western Blot Analysis (Figure 1a).   
 
Figure 1b shows the modulation of the generation of 
cytotoxic T lymphocyte (CTL) activity by PBMC obtained 
from elderly healthy subjects. The results of these 
experiments demonstrate that, whereas the anti-sense Aβ 
peptide (40 to 1) had little effect upon the generation of 
CTL activity in either group, Aβ peptides (1 to 42) (1 to 28) 
and (28 to 35) all blunted by at least 20 percent this specific 
memory immune function.  The data also unequivocally 
show a greater suppression of the generation of CTL 
activity when AlCl3 (nano
 M) was added to culture.  
 
The results obtained with PBMC show that Al significantly 
reduced the effect of PHA stimulation (Figure 1c), while it 
enhanced the effect of lipopolysaccharide (LPS) (Figure 
1d). Although Aβ alone was able to induce those effects, Al 
seemed to contribute to boost that effect even at a very low 
concentration (nano
  M) at least when the 25 to 35 Aβ 
fragment was involved. However, Al (nano
 M) was able to 
counteract LPS effect on PBMC when it was added to the 1 
to 28 and 25 to 35 fragments, as well as the 1 to 42 Aβ 
peptide, whereas there was no significant effect with the 
anti-sense Aβ peptide (40 to 1). Al leads to an inhibition of 
osteoblast function through activation of caspase 3, besides 
the mechanical effect of accumulating in bone. Al may 
actively modulate several cell functions, including 
circulating blood cells.  
 
 
Figure 1: (a) Western blot of caspase 3 expression by Saos-2 cells following: A) control, no experimental treatment; 
B) γinterferon-dexamethasone (nano
 M; 24 hour); C) Aβ (25 to 35) (nano
 M; 48 hour) - AlCl3 (nano
 M; 24 hour); (b) 
Modulation of PHA (5 micro gram per ml, 48 hour) proliferative response by Aβ and AlCl3 (nano M) (* p < 0.05); (c)  
Modulation by AlCl3  (nano
 M) of Aβ peptide. Effects on LPS stimulation (5 micro gram per ml, 48 hour) of normal 
PBMC (* p < 0.05); (d) Modulation by AlCl3 (nano
 M) of Aβ peptide. Effects on CTL (Raji as target, 7 days, 5 hour 
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T cell changes after small quantities of Al suggest that their 
putative role in AD etiology and/or progression depend on 
a cascade of events that may include common 
environmental factors. A full understanding of this effect is 
critical not only to identify possible disease mechanisms, 
but also to make an effective vaccine-based therapeutic 
approach to this devastating disease. [13] 
 
The Aβ protein and its metabolic peptides, by adhering to 
the endothelial lining of the lumen of blood vessels, trigger 
and sustain effects on immune cells, which may seriously 
hamper immune surveillance in subjects with AD. This 
effect may be further enhanced by monomeric Al both in T 
cells and in bone precursor cells. [14] Alternatively, we can 
evoke a process by which Al may penetrate the plasma 
membrane of immune cells and immune bone precursor 
cells, and alter either directly or via some yet to be 
identified metabolic step, the chromatin reading frame, or 
assembly, repair and rearrangement processes. One would 
invoke a genomic effect of Al on these cells, interactomic 
and metabolomic sequelae, which would manifest in the 
decreased T cell function and the increased propensity to 
apoptosis. The preliminary data we report here provide 
strong evidence that Al might significantly harm T cell 
subpopulations, and hinder cellular immune surveillance 
mechanisms. 
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